Dhanuka is India's second largest agro-chemical formulations company in domestic branded sales focusing on speciality molecules from global innovators. It has grown at revenue CAGR of around 11% over FY11-17, following an asset light model of producing formulations only and not technicals, which it sources from global partners. It has 11 tie-ups with global MNCs, which ensure new specialty products in Indian markets. Dhanuka has regularly launches new products, mainly in the fast-growing Herbicide/ Fungicide segments and over the years, it has a strong basket...
Recently, the stock price of Mayur Uniquoters Ltd. (Mayur Uniquoters) corrected by ~6% from 52-week high of Rs.479 despite reporting good set of numbers in the recent quarters. In the organized segment of the domestic synthetic leather industry, Mayur Uniquoters has the largest installed capacity with product finding application in footwear, automobile, furnishing and apparels among others. It has total installed capacity of 3.05mn meters per month spread across Jaitpura and Dhodsar near Jaipur, Rajasthan. The company has...
Recently, the stock price of Marico Ltd. (Marico) corrected by ~14% from 52-week high of Rs.349 as the company reported lower volume growth due to GST implementation and lower margin on account of higher copra prices in the recent quarters. With the strong brand equity in its two flagship brands, Parachute (associated with nourishment & purity) and Saffola (associated with health & wellness), Marico has successfully extended its brands into higher growth and underpenetrated categories, like, value added hair oil...
Recently, the stock price of Eris Lifesciences Ltd. (Eris) corrected by ~22 from 52-week high of Rs.728 as the company has reported below expected numbers in the recent quarters. Eris focuses on lifestyle related disorders, which are chronic in nature. Hence, the main target of the company is specialist and super specialist doctors. It is mainly into select therapeutic areas, such as, CVS, antidiabetics, vitamins, gastroenterology, anti-infectives and gynecology. In FY17, chronic segment generated 66% of total revenues. Even in the acute segment (34% of total revenues), the company focuses on...
Recently, the stock price of Tech Mahindra Ltd. (Tech Mahindra) corrected by ~15% from 52-week high of Rs.515 as it has reported lower revenue growth in the recent quarters due to slower-than-expected...
